IDH3A and central nervous system cancer: As isocitrate dehydrogenase (IDH) mutant underwent heterozygous mutations in > 70% glioma patients, the relationships between gene expressions of these 7 hypoxia-related key genes and IDH mutant were investigated in TCGA and CGGA database.